deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT02640820

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

A Prospective, Phase 2a Study to Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) in Subjects Ages 18 - 65 Years

Sponsor: RXi Pharmaceuticals, Corp.

Conditions Common Warts HPV (Human Papillomavirus) Periungual Warts Plantar Warts
Interventions Sensitizing DPCP Ointment Treatment DPCP Ointment
Updated 8 times since 2017 Last updated: Feb 21, 2018 Started: Dec 31, 2015 Primary completion: Jan 31, 2018 Completion: May 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Common Warts and HPV (Human Papillomavirus), this trial is ongoing. The trial is conducted by RXi Pharmaceuticals, Corp. and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Mar 2020 · 21 months · monthly snapshotActive Not Recruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Mar 2020 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  5. Jun 2018 — Mar 2020 [monthly]

    Active Not Recruiting PHASE2

▶ Show 3 earlier versions

  1. Mar 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Feb 2017 — Mar 2018 [monthly]

    Recruiting PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • RXi Pharmaceuticals, Corp.
Data source: RXi Pharmaceuticals, Corp.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations